Cytokinetics (CYTK) Shares Issued (2017 - 2025)
Historic Shares Issued for Cytokinetics (CYTK) over the last 14 years, with Q4 2024 value amounting to $3.0 million.
- Cytokinetics' Shares Issued fell 5056.55% to $3.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $53.0 million, marking a year-over-year increase of 18720.95%. This contributed to the annual value of $53.0 million for FY2024, which is 18720.95% up from last year.
- Latest data reveals that Cytokinetics reported Shares Issued of $3.0 million as of Q4 2024, which was down 5056.55% from -$43.6 million recorded in Q2 2024.
- Cytokinetics' Shares Issued's 5-year high stood at $93.6 million during Q1 2024, with a 5-year trough of -$43.6 million in Q2 2024.
- Moreover, its 5-year median value for Shares Issued was $3.6 million (2022), whereas its average is $9.0 million.
- The largest annual percentage gain for Cytokinetics' Shares Issued in the last 5 years was 253997.74% (2024), contrasted with its biggest fall of 86736.42% (2024).
- Over the past 5 years, Cytokinetics' Shares Issued (Quarter) stood at $34.2 million in 2020, then tumbled by 55.75% to $15.1 million in 2021, then plummeted by 76.24% to $3.6 million in 2022, then surged by 69.57% to $6.1 million in 2023, then tumbled by 50.57% to $3.0 million in 2024.
- Its Shares Issued stands at $3.0 million for Q4 2024, versus -$43.6 million for Q2 2024 and $93.6 million for Q1 2024.